| Literature DB >> 35222935 |
Ndidi U N Iwumene1, Daniel F Moseley1, Robert D C Pullin2, Michael C Willis1.
Abstract
Rhodium-catalyzed hydroacylation using alkynes substituted with pendant nucleophiles, delivers linear α,β-unsaturated enone intermediates with excellent regioselectivity. These adducts are used to construct a broad range of diversely substituted, saturated O-, N- and S-heterocycles in a one-pot process. Judicious choice of cyclisation conditions enabled isolation of O-heterocycles with high levels of diastereoselectivity. A variety of derivatisation reactions are also performed, generating functionalised hydroacylation products. This sequence serves as a general approach for the synthesis of fully saturated heterocycles. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35222935 PMCID: PMC8809418 DOI: 10.1039/d1sc06900d
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1Examples of biologically active compounds containing saturated N-, O- and S-heterocycles.
Scheme 1(a) Hydroacylation methods to various heterocycles via α,β-unsaturated enones; (b) our proposed alkyne hydroacylation route to stereodefined saturated heterocycles.
Scheme 2Intermolecular hydroacylation of aldehyde 1a and 4-pentyn-1-ol (2a).
Optimisation of cyclisation diastereoselectivity using alkynol 2b
|
| |||
|---|---|---|---|
| Entry | Acid (equiv.) | Yield | dr |
| 1 | — | 86 | 4 : 1 |
| 2 | — | 64 | 3 : 1 |
| 3 |
| 62 | 11 : 1 |
| 4 | MsOH (2.0) | 33 | >20 : 1 |
| 5 |
| 87 | 6.8 : 1 |
| 6 | MsOH (0.2) | 98 | 4.4 : 1 |
| 7 | Sc(OTf)3 (0.2) | 78 | 4.9 : 1 |
| 8 | Ti( | 96 | 4.2 : 1 |
| 9 | AlCl3 (0.2) | 87 | 4.4 : 1 |
| 10 | BF3·OEt2 | 76 | 4.4 : 1 |
| 11 | BCl3 (0.2) | 83 | 7.3 : 1 |
| 12 | HCl in dioxane (2.0) | 95(87) | 13 : 1 |
Determined using 1H NMR spectroscopy with methyl-3,5-dinitrobenzoate as an internal standard. Isolated yield in parentheses.
Measured by 1NMR spectroscopy on the unpurified reaction mixture.
Reaction at room temperature.
>20 : 1 l : b regioselectivity, and >20 : 1 5a : 1a determined by 1H NMR spectroscopy.
13.9 : 1 l : b regioselectivity, and 6.2 : 1 5a : 1a determined by 1H NMR spectroscopy.
Scheme 3Aldehyde and alkyne scope; diastereomeric ratios were determined by 1H NMR spectroscopic analysis of the crude reaction mixture; aisolated yield of a single major diastereoisomer; btotal isolated yield of both diastereoisomers; creactions with step (i) only; dreactions carried out on 0.2 mmol scale; estep (i) conditions: alkyne (2.0 equiv.), Rh(nbd)2BF4 (5 mol%), dppe (5 mol%), acetone (0.15 M), 55 °C, 2 h; fstep (i) conditions: Rh(nbd)2BF4 (10 mol%), dcpm (10 mol%), acetone (0.15 M), 55 °C, 4 h; g>20 : 1 dr with respect to ring closure, 1 : 1 dr with respect to the aldehyde stereocentre; h1.33 equiv. alkyne used; ip-TsOH used in cyclisation step instead of HCl in dioxane; j5 mol% DPEPhos used as ligand instead of dcpe.
Scheme 4Tandem hydroacylation/S-conjugate addition to access thiane 7a.
Optimisation of one-pot hydroacylation/S-conjugate addition with t-Bu sulfide alkyne 6ba
|
| ||||
|---|---|---|---|---|
| Entry | Equiv. TFA | Time/h | Conc./M | Yield |
| 1 | 2 | 19 | 0.2 | 61 |
| 2 | 5 | 19 | 0.2 | 54 |
| 3 | 10 | 19 | 0.2 | 55 |
| 4 | 2 | 6 | 0.2 | 57 |
| 5 | 2 | 4 | 0.5 | 64 |
| 6 | 2 | 4 | 0.1 | 74(82) |
| 7 | 2 | 4 | 0.025 | 70 |
100% conversion for step (i) based on analysis by 1H NMR spectroscopy.
Yields determined using 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as internal standard; isolated yields in parentheses.
Scheme 5(A and B) Tandem hydroacylation/S-conjugate addition: scope of aldehydes and unsubstituted t-Bu sulfide alkynes; a16 h; b22 h, 4.0 equiv. TFA; cstep (i) 74% conversion based on analysis of 1H NMR; d2 h, 1.0 equiv. TFA; estep (i) 89% conversion based on analysis of 1H NMR; f10 equiv. of TFA; (C) possible mechanism of competing pathway.
Scheme 6Transformations of saturated heterocycle hydroacylation adducts: (i) Rh(nbd)2BF4 (5 mol%), dcpm (5 mol%), (EtO)3SiH (10 equiv.), CH2Cl2 (0.15 M), r.t, 24 h; (ii) Rh(nbd)2BF4 (5 mol%), Xantphos (5 mol%), phenylacetylene (2.0 equiv.), DCE, 100–120 °C, 21 h; (iii) Rh(nbd)2BF4 (5 mol%), dcpe (5 mol%), CuBr (2.0 equiv.), Ag2CO3 (1.0 equiv.), phenylacetylene (2.0 equiv.), DCE (0.075 M), 80 °C, 16 h; (iv) Eu(OTf)3, LiBH4, −78 °C, Et2O, 2–3 h; (v) NH2OH·HCl (4.0 equiv.), pyridine (4.0 equiv.), MeOH, 60 °C, 20 h; (vi) Ac2O (4.0 equiv.), pyridine, 120 °C, 20 h; (vii) m-CPBA (3.0 equiv.), DCM (0.16 M), r.t, 3h; (viii) NH4OAc (5.5 equiv.), AgNO3 (0.8 equiv.), t-BuOH, 60 °C, 16 h.